PedAM
Pediatric Disease Annotations & Medicines
| Disease | proteinuria |
| Phenotype | C1561644|chronic kidney disease (ckd) |
| Sentences | 6 |
| PubMedID- 23167771 | We evaluated the antiproteinuric effect of pct in non-dialysis chronic kidney disease (ckd) patients with proteinuria greater than 0.5 g/24 h persisting despite anti-ras therapy titrated to minimize proteinuria in the absence of adverse effects. |
| PubMedID- 22333173 | Objective: to evaluate the efficacy and safety of high-dose irbesartan in the treatment of mild and moderate proteinuria in patients with chronic kidney disease (ckd). |
| PubMedID- 23552860 | We compared the therapeutic effects of fasudil on the spontaneously hypercholesterolemic (shc) rat, a model of chronic kidney disease (ckd) with proteinuria, with those of the angiotensin receptor blocker olmesartan (ol) by paying attention to the proteinuria and the macrophage phenotype. |
| PubMedID- 26151753 | However, the effects of statins on renal outcomes, including decline in estimated glomerular filtration rate (egfr) and proteinuria in patients with chronic kidney disease (ckd), are controversial. |
| PubMedID- 21852669 | Whether central measures of bp or vascular stiffness are associated with increased risk of proteinuria in patients with chronic kidney disease (ckd) is unknown. |
| PubMedID- 21677444 | We hypothesized that renal tlr4 expression plays a role in chronic kidney disease (ckd) and is associated with proteinuria, kidney function, histological diagnosis, and inflammatory mediators. |
Page: 1